IDXX · IDEXX Laboratories, Inc.

Healthcare NMS United States idexx.com ↗
Val Gro Qua Mom Sta Cap P/S8.73 P/E Fwd P/E30.15 PEG2.82 52W –  RSI Target$698.92 (+38.5%) Beta1.54 Div
Loading chart…
RSI ()
Pattern Overlays
Loading patterns…
Diagnostics & Research Westbrook, United States 11,000 employees
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 31 Overbought · 100
Signal Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
6Bullish
5Bearish
0Neutral

Key Signals 2

▲ Inv. Head & Shoulders Major reversal 2026-08-04 · $579.31
Inv. H&S neckline ~$579.31 broken — major bullish reversal
Learn more →
▲ Double Bottom Major reversal 2026-08-04 · $577.15
Two lows ~$527.35 — bullish reversal confirmed
Learn more →

Momentum Signals 9

▲ MACD Bullish Crossover 2026-05-20 · $553.58
▲ MACD Bullish Crossover 2026-07-06 · $564.98
▲ MACD Bullish Crossover 2026-07-28 · $569.54
▲ Bull Flag 2026-08-04 · $581.55

View overlays on the price chart via Overview tab → Pattern Overlays.

Next Earnings Nov 02, 2026
Beat Rate 100%
Consensus BUY
Analyst Upside +38.5%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
100% 8/8 quarters
Wall Street Consensus
BUY
8
5
1
BuyHoldSell
Price Target Range
$698.92 +38.5% upside
Low $470 High $805
Consensus Current price
Wall Street Analyst Ratings
Sort by
Firm Rating Change Action Date
Profitability
Gross Margin 62.45%Last 12 Months
Operating Margin 34.98%Last 12 Months
Return on Equity 74.21%Last 12 Months
Revenue Growth 9.70%Year over Year
Free Cash Flow 909.37MLast 12 Months
Free Cash Flow Yield Last 12 Months
Balance Sheet
Debt / Equity 67.97Most Recent Quarter
Current Ratio 1.17Most Recent Quarter
Cash 196.93MMost Recent Quarter
Total Debt 1.10BMost Recent Quarter
Net Debt Most Recent Quarter
How IDXX Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap39.76B
Enterprise Value40.66B
Trailing P/E35.59
Forward P/E30.15
PEG Ratio (5yr)2.82
Price/Sales (ttm)8.73
Price/Book (mrq)24.69
EV/Revenue8.93
EV/EBITDA25.07
Share Statistics
Avg Vol (3m)621.22K
Shares Outstanding78.78M
Float78.50M
% Held by Insiders0.22%
% Held by Institutions96.74%
Short Ratio3.41
Short % of Float3.04%
Profitability
Gross Margin62.45%
Operating Margin (ttm)34.98%
Profit Margin25.03%
Return on Assets (ttm)27.08%
Return on Equity (ttm)74.21%
Income Statement
Revenue (ttm)4.55B
Revenue Growth (yoy)9.70%
Gross Profit (ttm)2.84B
EBITDA1.62B
Net Income (ttm)1.14B
Diluted EPS (ttm)14.18
EPS Growth (yoy)17.60%
Balance Sheet
Total Cash (mrq)196.93M
Total Debt (mrq)1.10B
Debt / Equity (mrq)67.97
Current Ratio (mrq)1.17
Book Value / Share20.45
Operating CF (ttm)1.37B
Free Cash Flow (ttm)909.37M
Trading & Dividends
Beta (5Y)1.54
50-Day MA556.71
200-Day MA604.57
Fwd Dividend YieldN/A
Payout Ratio0.00%

No dividend history available for IDXX.

Ownership Breakdown
Institutional 96.74% Insider 0.22% Public 3.0%
Short Interest 3.04% of float
Moderate
Institutional 13F Holdings

Famous investors who disclosed a position in IDXX in their latest SEC 13F filing.

Loading…
Insider Transactions
Date Insider Role Transaction Shares Price Value